12 Mar Cellular Logistics co-founder, Dr. Amish Raval, will be a featured speaker as an awardee of the NHLBI Preclinical Catalyze program
Interested in learning more about the Catalyze program? Join us on March 19 at 12pm ET for a live webinar where a panel of four funded investigators will describe their Catalyze project and summarize key takeaways from the program. Time will be reserved for audience questions.
March 19, 2025 12:00pm – 1:00pm Eastern
Title: Peer-to-Peer Learning: Catalyze Awardee Panel Presentation & Discussion
Presenters: Drs. Raymond Benza, Rebekah Gundry, Amish Raval, and Peter Vanderslice
Register: https://rtiorg.zoom.us/webinar/register/WN_TrqToa6pSX-1yckXf6eAOw
Dr. Amish Raval
Amish Raval is developing a biologic at the University of Wisconsin School of Medicine and Public Health aimed at preventing heart failure (HF) following myocardial infarction (MI). His team has created a novel extracellular matrix (ECM) derived from human cardiac fibroblasts, which educates macrophages to assume pro-reparative properties. This innovative ECM, produced from human induced pluripotent stem cells (iPSCs), offers a scalable and reproducible approach to regenerative medicine, with the potential to transform post-MI heart repair.